Clinical Trials Browser

PSA Level Greater Than 0.03 × Androgen Antagonists × Clear all

NCT03541850 2025-11-06

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Phase 2 Active not recruiting

PSA Level Greater Than 0.03